Teriparatide biosimilar (Zhongke Shenglongda Biotech)

Using salmon calcitonin nasal spray and teriparatide injection as positive controls, the dose-effect relationship and safety of recombinant human parathyroid hormone (1-34) in the treatment of osteoporosis in postmenopausal women were explored and evaluated, providing a basis for determining the safe and effective dose of the test drug in Phase III clinical trials.